Last Price
0.013
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Overview
Market Cap
2 Million
Shares Outstanding
167 Million
Avg Volume
0
Avg Price (50 Days)
0.01
Avg Price (200 Days)
0.01
PE Ratio
-1.30
EPS
-0.01
Earnings Announcement
28-Aug-2025
Previous Close
0.01
Open
0.01
Day's Range
0.013 - 0.013
Year Range
0.008 - 0.021
Trading Volume
15,800
Price Change Highlight
1 Day Change
0.00%
5 Day Change
0.00%
1 Month Change
0.00%
3 Month Change
-27.78%
6 Month Change
18.18%
Ytd Change
-27.78%
1 Year Change
-43.48%
3 Year Change
-96.62%
5 Year Change
-93.33%
10 Year Change
-93.33%
Max Change
-99.02%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Hexima Limited, a biotechnology company, engages in the research and development of plant-derived proteins and peptides for applications as human therapeutics. The company's lead drug candidate is the plant defensin, pezadeftide, which is in phase IIb clinical trials for the treatment of fungal toenail infections in Australia and New Zealand. Hexima Limited was incorporated in 1997 and is based in Preston, Australia.
Discussions
Be the first to like this.
Showing 0 of 0 comments
Post a Comment
Latest Videos
![[New IPO] Oxford Innotech Berhad, a precision engineering and automation solutions provider, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1208/Thumbnail_.png)
![[New IPO] Enproserve Group Berhad, a plant maintenance specialist in the O&G sector, plans to list on the Ace Market!](https://mqac.i3investor.com/img/video_thumbnail/1198/Thumbnail__(10).png)
Apps
Top Articles
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
{uid}
{comment}
Just now